TA-1

Scientific Overview

Thymosin alpha-1 (TA-1) is a 28–amino-acid thymic peptide. Reviews examine its activity in innate and adaptive immune-cell models and summarize a large clinical literature without this page restating outcome claims.

Mechanism focus

Laboratory work explores T-cell and dendritic-cell related signaling. It is a thymic immune peptide, distinct from thymosin beta-4 fragments such as TB-500.

Research Use Cases

• Immune-cell signaling assays
• Thymic peptide characterization
• Innate and adaptive immunity models
• Analytical confirmation of the thymosin alpha-1 sequence

Use-Case Study Notations

• Case-study notation: narrative reviews summarize thymosin alpha-1 as a thymic immune peptide.
• Case-study notation: later reviews compile human clinical-trial literature under research and medical headings.
• TB-500 is a different thymosin fragment. Sequence identity should be confirmed on the certificate of analysis.

Selected Studies

1. 01 Thymosin alpha 1: from bench to bedsidePubMed 17600290
2. 02 Thymosin α1 and cancer: action on immune effector and tumor target cellsPubMed 23045967
3. 03 Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKKPubMed 29077041
4. 04 Therapeutic applications of thymosin peptides: a patent landscape 2018-presentPubMed 38131310
5. 05 Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisPubMed 28394330

Related compounds

KPV · NAD+